product summary
Loading...
company name :
MyBioSource
product type :
protein
product name :
Growth Hormone (GH), Human Pituitary - High Purity
catalog :
MBS173341
quantity :
0.1 mg
price :
245 USD
more info or order :
product information
catalog number :
MBS173341
products type :
Protein
products full name :
Growth Hormone (GH), Human Pituitary - High Purity
products short name :
Growth Hormone
products name syn :
HGH; Somatropin; Growth Hormone (GH), Native Human Hormone - >95% (SDS-PAGE)
other names :
growth hormone; Somatotropin; somatotropin; pituitary growth hormone; growth hormone 1; Growth hormone; GH; GH-N; Growth hormone 1; Pituitary growth hormone
products gene name :
GH
other gene names :
GH1; GH1; GH; GHN; GH-N; hGH-N; IGHD1B; GH; GH-N
uniprot entry name :
SOMA_HUMAN
sequence length :
217
purity :
>= 95% (SDS-PAGE)
form :
Lyophilized
storage stability :
At -20 degree C
other info1 :
Source: Human Pituitary Glands
other info2 :
Reconstitution: Reconstitute using neutral pH buffer of choice. Avoid extreme high and low pH. Recertification: 5 years. Protein: >= 1.0 mg/mg (Accubind ELISA). Contaminants: LH: <=42.5 IU/mg, FSH: <=18.75 IU/mg, PRL: <=0.005 mg/mg, TSH: <=0.0425 IU/mg (All assayed by ELISA and < 0.5% w/w)
products categories :
Proteins; Antigens; Standards/controls; Native Proteins; Growth Hormone (gh)
products description :
MyBioSource offers high purity human pituitary Growth Hormone (GH) for researchers and clinical diagnostic manufacturers. GROWTH HORMONE IS FOR RESEARCH AND IN-VITRO MANUFACTURING USE ONLY. THIS PRODUCT NOT FOR HUMAN USE. Technical support, bulk quantities and aliquoting available. Growth hormone (GH), also known as somatropin, is a protein-based peptide hormone. Growth Hormone stimulates growth, cell reproduction and regeneration animals and human.
ncbi gi num :
183157
ncbi acc num :
AAA98618.1
ncbi mol weight :
~22,000
ncbi pathways :
Adipogenesis Pathway (198832); Cytokine Signaling In Immune System Pathway (366171); Cytokine-cytokine Receptor Interaction Pathway (83051); Cytokine-cytokine Receptor Interaction Pathway (460); Endochondral Ossification Pathway (198812); Growth Hormone Receptor Signaling Pathway (477128); Immune System Pathway (106386); Jak-STAT Signaling Pathway (83077); Jak-STAT Signaling Pathway (488); Metabolism Of Proteins Pathway (106230)
ncbi summary :
The protein encoded by this gene is a member of the somatotropin/prolactin family of hormones which play an important role in growth control. The gene, along with four other related genes, is located at the growth hormone locus on chromosome 17 where they are interspersed in the same transcriptional orientation; an arrangement which is thought to have evolved by a series of gene duplications. The five genes share a remarkably high degree of sequence identity. Alternative splicing generates additional isoforms of each of the five growth hormones, leading to further diversity and potential for specialization. This particular family member is expressed in the pituitary but not in placental tissue as is the case for the other four genes in the growth hormone locus. Mutations in or deletions of the gene lead to growth hormone deficiency and short stature. [provided by RefSeq, Jul 2008]
uniprot summary :
GH: Plays an important role in growth control. Its major role in stimulating body growth is to stimulate the liver and other tissues to secrete IGF-1. It stimulates both the differentiation and proliferation of myoblasts. It also stimulates amino acid uptake and protein synthesis in muscle and other tissues. Defects in GH1 are a cause of growth hormone deficiency isolated type 1A (IGHD1A); also known as pituitary dwarfism I. IGHD1A is an autosomal recessive deficiency of GH which causes short stature. IGHD1A patients have an absence of GH with severe dwarfism and often develop anti-GH antibodies when given exogenous GH. Defects in GH1 are a cause of growth hormone deficiency isolated type 1B (IGHD1B); also known as dwarfism of Sindh. IGHD1B is an autosomal recessive deficiency of GH which causes short stature. IGHD1B patients have low but detectable levels of GH. Dwarfism is less severe than in IGHD1A and patients usually respond well to exogenous GH. Defects in GH1 are the cause of Kowarski syndrome (KWKS); also known as pituitary dwarfism VI. Defects in GH1 are a cause of growth hormone deficiency isolated type 2 (IGHD2). IGHD2 is an autosomal dominant deficiency of GH which causes short stature. Clinical severity is variable. Patients have a positive response and immunologic tolerance to growth hormone therapy. Belongs to the somatotropin/prolactin family. 4 isoforms of the human protein are produced by alternative splicing. Protein type: Secreted, signal peptide; Hormone; Secreted. Chromosomal Location of Human Ortholog: 17q24.2. Cellular Component: extracellular space; extracellular region. Molecular Function: protein binding; growth hormone receptor binding; growth factor activity; prolactin receptor binding; metal ion binding; hormone activity. Biological Process: positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of phosphoinositide 3-kinase cascade; positive regulation of MAP kinase activity; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of tyrosine phosphorylation of Stat5 protein; positive regulation of receptor internalization; positive regulation of JAK-STAT cascade; positive regulation of multicellular organism growth; glucose transport; JAK-STAT cascade; response to estradiol stimulus; positive regulation of tyrosine phosphorylation of Stat3 protein. Disease: Isolated Growth Hormone Deficiency, Type Ia; Isolated Growth Hormone Deficiency, Type Ib; Isolated Growth Hormone Deficiency, Type Ii; Kowarski Syndrome
size1 :
0.1 mg
price1 :
245 USD
size2 :
1 mg
price2 :
755
more info or order :
company information
MyBioSource
P.O. Box 153308
San Diego, CA 92195-3308
sales@mybiosource.com
https://www.mybiosource.com
1-888-627-0165
headquarters: USA
MyBioSource, LLC was orginally founded in Vancouver by three enthusiastic scientists who are passionate about providing the world with the best reagents available. Together, they form a company with a big vision known as MyBioSource. MyBioSource is now located in San Diego, California, USA.

"MyBioSource's number 1 vision is to be the world's number 1 quality reagents provider."

Our goal is to provide researchers, scientists and customers alike with a one-stop-shop for all of their reagents needs, whether it is monoclonal antibody, polyclonal antibody, recombinant protein, peptide, etc...

"MyBioSource offers the best products at unbeatable prices."

Please spend a few minutes to browse our online catalogs and see the wide range of products available. We ship our products through our shipping/distribution facility in San Diego, California, USA.

Would you like to receive email and e-newsletter from MyBioSource about new products, special offers and events? Please click here to join our Mailing List!